Reata - Prakiraan wutah bathi resik saben saham kanggo taun ngarep RETA

Logo korporat perusahaan Reata Pharmaceuticals (RETA)

Reata Pharmaceuticals (RETA) is developing a biopharmaceutical network to combat rare neurodegenerative pathologies, leveraging the patent protection of Skyclarys. The consensus earnings per share (EPS) forecast vector demonstrates the impact of tight monetary policy on multiples, while the -2.40 level records fresh values. Revenues are constrained by insurance reimbursement complexities and marketing expenses. Consequently, the company is implementing an unrivaled therapy method for Friedreich's ataxia.

Reata (RETA): Prakiraan wutah bathi resik saben saham kanggo taun ngarep saka 04.07.2022 nganti 07.10.2023

Ringkesan rincian data analitis Reata (RETA)

Analisis fundamental perusahaan:RETA, Reata Pharmaceuticals
Produk dadi Reata Pharmaceuticals Inc

Reata Pharmaceuticals (RETA) maintains exceptional pricing power due to its monopoly status in Friedreich's ataxia therapy, which is directly reflected in analysts' valuations of n+1 net profit dynamics. This indicator measures the expected percentage growth in earnings per share, allowing investors to assess the sustainability of expansion rates and promptly identify risks of a slowdown in the business's fundamental growth.

Analisis pesaing Reata Pharmaceuticals

Prakiraan wutah bathi resik saben saham kanggo taun ngarep Jazz Pharmaceuticals|CYTK: Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep PTC Bio (PTCT)|SRRK - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Centessa Pharmaceuticals PLC CNTA|Dyne Pharma (DYN) - Prakiraan wutah bathi resik saben saham ing taun ngarep|EWTX - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Rapport Therapeutics, Inc.|ALMS: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Kempharm ZVRA|Prakiraan wutah bathi saben saham kanggo taun ngarep CTNM|Prakiraan wutah bathi resik saben saham ing taun ngarep Larimar Corp LRMR|Prakiraan wutah bathi kanggo taun ngarep CAPR|TRDA - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep PTHS (Channel Therapeutics Corp)|MediciNova Corp (MNOV) - Prakiraan wutah bathi resik saben saham ing taun ngarep|Serina Pharma - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep BioXcel Therapeutics|PMN: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep Apimeds Pharmaceuticals, Inc.|Prakiraan wutah bathi saben saham kanggo taun ngarep AEON|NLS Pharmaceutics AG - Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Bionomics Ltd. (BNOX)|HUGE (FSD Pharma Inc.) - Dinamika bathi saben saham sing diarepake ing taun ngarep